Services
Company
Legal and Governance
Publication Library / Publications
Rifaximin-α is associated with reductions in emergency department resource use in UK patients with hepatic encephalopathy: Real world evidence from the IMPRESS study
Authors
M Hudson, P Di Maggio, R Cipelli, R Aspinall
Journal
United European Gastroenterology Journal
Therapeutic Area
Infectious diseases and vaccines
Center of Excellence
Real-world Evidence & Data Analytics
Year
2017
Read full article